Mayer J, Cheeseman M A, Twaroski M L
Food and Drug Administration, Division of Food Contact Notifications, HFS-275, 5100 Paint Branch Parkway, College Park, MD 20740, USA.
Regul Toxicol Pharmacol. 2008 Feb;50(1):50-8. doi: 10.1016/j.yrtph.2007.09.005. Epub 2007 Nov 19.
OncoLogic and MultiCASE (MCASE) are two structure-activity relationship (SAR) analysis software programs available to screen compounds for potential carcinogenicity. Ashby-Tennant structural alerts [Ashby, J., Tennant, R.W., 1991. Definitive relationships among chemical structure, carcinogenicity, and mutagenicity for 301 chemicals tested by the US NTP. Mutat. Res. 257, 229-306] and genetic toxicity testing may also be used to assess/predict this endpoint. Six-hundred and fifty compounds tested for carcinogenicity whose results were tabulated in the Carcinogenic Potency Database (CPDB) were used to validate and compare the predictivity of OncoLogic (Version 4.1), MCASE (Version 3.1), Ashby-Tennant structural alerts, and genetic toxicity testing, individually and in combination. The sensitivity of the methods for predicting carcinogens and the specificity for predicting non-carcinogens was examined. Potent carcinogens, defined as those with TD(50) values of less than 6.25 mg/kg bw/d, were then examined separately. It is concluded that SAR analysis programs and structural alerts perform well for compounds with low human exposure levels and have the potential to supplement the results of routinely requested genetic toxicity tests in a weight-of-evidence approach in predicting carcinogenicity, although each method of analysis has limitations regarding applicability.
OncoLogic和MultiCASE(MCASE)是两个可用于筛选具有潜在致癌性化合物的构效关系(SAR)分析软件程序。阿什比-坦南特结构警示[阿什比,J.,坦南特,R.W.,1991年。美国国家毒理学计划测试的301种化学物质的化学结构、致癌性和诱变性之间的确切关系。突变研究。257,229 - 306]以及遗传毒性测试也可用于评估/预测该终点。在致癌效力数据库(CPDB)中列出结果的650种经致癌性测试的化合物被用于单独和联合验证及比较OncoLogic(4.1版)、MCASE(3.1版)、阿什比-坦南特结构警示以及遗传毒性测试的预测能力。研究了预测致癌物的方法的敏感性和预测非致癌物的特异性。然后分别检查了定义为经口半数致死剂量(TD(50))值小于6.25毫克/千克体重/天的强效致癌物。得出的结论是,构效关系分析程序和结构警示对于人类接触水平低的化合物表现良好,并且有可能在预测致癌性的证据权重方法中补充常规要求的遗传毒性测试结果,尽管每种分析方法在适用性方面都有局限性。